In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab
Djordje Atanackovic(University of Maryland, Baltimore), Tim Luetkens(University of Maryland, Baltimore), Marielle Chiron(Sanofi (France)), Christa Shorter(University of Utah), Rodney R. Miles(Inserm), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Mary Steinbach(University of Utah), Srinivas K. Tantravahi(University of Utah), Douglas W. Sborov(University of Utah), Fiorella Iglesias Cardenas(University of Utah), Nicolaus Kröger(Universität Hamburg), Sara Yousef(Huntsman Cancer Institute), Sabarinath Venniyil Radhakrishnan(University of Utah)
Cited by 37
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396